Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets.

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This chronic lung ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

The study, called the ABRA trial, was led by King’s College London researchers and published in The Lancet Respiratory ...

It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...

Research in idiopathic pulmonary fibrosis is progressing rapidly, with the goal of delivering more treatments to patients at ...

Doctors are hailing a new way to treat serious asthma and chronic obstructive pulmonary disease (COPD) attacks that marks the ...

The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulm ...

Thymic stromal lymphopoietin (TSLP) is an IL-7 cytokine produced by epithelial and stromal cells in the lung and acts as an ...